TCP
MRK icon

Tourbillon Capital Partners’s Merck MRK Stock Holding History

Tourbillon Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-445,400
Closed -$24.1M – 64
2017
Q4 		$23.9M Buy
+445,400
New +$24.7M 0.88% 29

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tourbillon Capital Partners's MRK Position: Q1 2018 in Review

Tourbillon Capital Partners sold out of Merck (MRK) in Q1 2018, closing a stake of 445,400 shares — an estimated $24.1M sold.

Tourbillon Capital Partners first reported a position in MRK in Q4 2017 and held it in 1 quarter. The position peaked at $23.9M in Q4 2017. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

  • Tourbillon Capital Partners reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
  • Tourbillon Capital Partners sold 445,400 Merck shares in Q1 2018, an estimated $24.1M.
  • Tourbillon Capital Partners first reported a position in Merck in Q4 2017 and held it in 1 quarter.
  • Tourbillon Capital Partners's Merck position peaked at $23.9M in Q4 2017.
  • 1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Tourbillon Capital Partners's 13F filing for Q1 2018, filed 15 May 2018.